| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/16/2010 | WO2010054154A3 Bifidobacteria crispr sequences |
| 09/16/2010 | WO2010053539A3 Methods for detecting colorectal diseases and disorders |
| 09/16/2010 | WO2010053522A3 Methods for identifying and producing neural stem and progenitor cells and their progeny |
| 09/16/2010 | WO2010047519A3 Heart tissue specific gene mmh1 |
| 09/16/2010 | WO2010046648A3 Diagnostic test for streptococcus equi |
| 09/16/2010 | WO2010039778A3 Mammalian genes involved in infection |
| 09/16/2010 | WO2010035261A3 Amyloid beta-peptides and methods of use thereof |
| 09/16/2010 | WO2006113246A3 Small activating rna molecules and methods of use |
| 09/16/2010 | US20100235946 Plant transcriptional factors as molecular markers |
| 09/16/2010 | US20100235941 F.oxysporum f.sp. melonis race 1,2-resistant melons |
| 09/16/2010 | US20100235937 Production of transgenic avian organisms employing embryonic stem cells |
| 09/16/2010 | US20100235935 Plasma anti-diabetic nucb2 peptide (pladin) and uses thereof |
| 09/16/2010 | US20100235933 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 09/16/2010 | US20100235931 Novel Neurological Function of mPKCI |
| 09/16/2010 | US20100234463 Method for Identifying Modulators of Gamma Secretase or Notch |
| 09/16/2010 | US20100234445 Patterns of known and novel small RNAS in human cervical cancer |
| 09/16/2010 | US20100234381 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 09/16/2010 | US20100234348 Compositions and methods for potentiating antibiotic activity |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234292 Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer |
| 09/16/2010 | US20100234287 Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics |
| 09/16/2010 | US20100234245 Primers and probes for the detection of streptococcus pneumoniae |
| 09/16/2010 | US20100234242 DNA Methylation Changes Associated with Major Psychosis |
| 09/16/2010 | US20100234241 DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES |
| 09/16/2010 | US20100234239 Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancers |
| 09/16/2010 | US20100233828 Site Selectively Tagged and Templated Molecularly Imprinted Polymers for Sensor Applications |
| 09/16/2010 | US20100233756 Animal Feed Kibble with Protein-Based Core and Related Methods |
| 09/16/2010 | US20100233755 Pdx1-expressing dorsal and ventral foregut endoderm |
| 09/16/2010 | US20100233754 Vessel Transporting Apparatus and Method |
| 09/16/2010 | US20100233753 Optical measuring device and method therefor |
| 09/16/2010 | US20100233752 Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases |
| 09/16/2010 | US20100233751 Apparatus and method for monitoring cultures |
| 09/16/2010 | US20100233750 Human Blood Brain Barrier Model |
| 09/16/2010 | US20100233749 Device with biological component and method of making to achieve a desired figure of merit |
| 09/16/2010 | US20100233748 Device with biological component and method of making to achieve a desired transfer function |
| 09/16/2010 | US20100233747 Method and means for the enzymatic determination of ethanol |
| 09/16/2010 | US20100233746 Inflammation and Oxidative Stress Level Assay |
| 09/16/2010 | US20100233745 Detecting a microorganism strain in a liquid sample |
| 09/16/2010 | US20100233744 Enzyme substrates for visualizing acidic organelles |
| 09/16/2010 | US20100233743 Bisubstrate fluorescent probe binding to protein kinases |
| 09/16/2010 | US20100233742 Method of Quantifying Autoinducer-2 |
| 09/16/2010 | US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/16/2010 | US20100233727 Marker for arrhythmia risk |
| 09/16/2010 | US20100233726 Tandem fluorescent protein constructs |
| 09/16/2010 | US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 09/16/2010 | US20100233721 Apparatus and methods for detecting dna in biological samples |
| 09/16/2010 | US20100233720 Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection |
| 09/16/2010 | US20100233719 Genetic Markers for Predicting Disease and Treatment Outcome |
| 09/16/2010 | US20100233718 Non-invasive technique for conducting skin inflammatory disease pharmaco-genomic studies and diagnoses thereof |
| 09/16/2010 | US20100233717 Methods for detecting toxigenic microbes |
| 09/16/2010 | US20100233716 Transplant rejection markers |
| 09/16/2010 | US20100233715 Method of nucleic acid amplification and measuring reagent and reagent kit therefor |
| 09/16/2010 | US20100233714 Multistate affinity ligands for the separation and purification of antibodies, antibody fragments and conjugates of |
| 09/16/2010 | US20100233713 Method for treating a solution in order to destroy any ribonucleic acid after amplification |
| 09/16/2010 | US20100233712 Method for Early Detection of Cancers |
| 09/16/2010 | US20100233711 Gene encoding labyrinthin, a marker for cancer |
| 09/16/2010 | US20100233710 Nucleic acid binding dyes and uses therefor |
| 09/16/2010 | US20100233709 Abscription based molecular detection |
| 09/16/2010 | US20100233708 Split flow device for analyses of specific-binding partners |
| 09/16/2010 | US20100233707 Materials and methods for predicting recurrence of non-small cell lung cancer |
| 09/16/2010 | US20100233706 Methods to fix and detect nucleic acids |
| 09/16/2010 | US20100233705 Method or system using biomarkers for the monitoring of a treatment |
| 09/16/2010 | US20100233704 Methods of detecting lung cancer |
| 09/16/2010 | US20100233703 Emx2 in cancer diagnosis and prognosis |
| 09/16/2010 | US20100233702 Method to predict response to treatment for psychiatric illnesses |
| 09/16/2010 | US20100233701 Use of non-clonal chromosomal aberrations for cancer research and clinical diagnosis |
| 09/16/2010 | US20100233700 Ubiad1 gene and hyperlipidemia |
| 09/16/2010 | US20100233699 Primers and methods for the detection and discrimination of nucleic acids |
| 09/16/2010 | US20100233698 Sealed microarrays with transparent cover are placed within indium tin oxide heater; condensation prevention; PCR; high-throughput and low-cost amplification of nucleic acids |
| 09/16/2010 | US20100233697 Method for standarizing surface binding of a nucleic acid sample for sequencing analysis |
| 09/16/2010 | US20100233696 Methods, flow cells and systems for single cell analysis |
| 09/16/2010 | US20100233695 Molecular diagnosis and typing of lung cancer variants |
| 09/16/2010 | US20100233694 Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
| 09/16/2010 | US20100233693 Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
| 09/16/2010 | US20100233692 Fluorescently labeled fusion protein for assaying adenosine triphosphate |
| 09/16/2010 | US20100233691 Gene Expression Profiling for Identification, Monitoring and Treatment of Prostate Cancer |
| 09/16/2010 | US20100233690 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 09/16/2010 | US20100233689 Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| 09/16/2010 | US20100233688 multiplex PCR; analyzing fluorescence-labeled exon fragments via capillary electrophoresis |
| 09/16/2010 | US20100233687 Method and system for temperature correction in thermal melt analysis |
| 09/16/2010 | US20100233686 Multiplex Quantitative Nucleic Acid Amplification and Melting Assay |
| 09/16/2010 | US20100233685 Two-Color Fluorescent Reporter for Alternative Pre-MRNA Splicing |
| 09/16/2010 | US20100233684 Method for determining inflammatory disease |
| 09/16/2010 | US20100233683 Amplification of dna fragments |
| 09/16/2010 | US20100233682 Fluid processing and volume determination system |
| 09/16/2010 | US20100233681 Method for cell based assays |
| 09/16/2010 | US20100233680 Gene Expression Profiles and Methods of Use |
| 09/16/2010 | US20100233679 Detection of truncation mutations in a large background of normal dna |
| 09/16/2010 | US20100233678 Tunable affinity ligands for the separation and detection of target substances |
| 09/16/2010 | US20100233677 Full genome sequences of human rhinovirus strains |
| 09/16/2010 | US20100233676 High affinity fluorochrome binding peptides |
| 09/16/2010 | US20100233675 Analyte manipulation and detection |
| 09/16/2010 | US20100233674 Cells for detection and production of influenza and parainfluenza viruses |
| 09/16/2010 | US20100233296 Method and system for producing a substance or a signal with a coagulating or anticoagulant effect |
| 09/16/2010 | US20100233249 Contraceptive methods and compositions related to proteasomal interference |
| 09/16/2010 | US20100233239 Templated islet cells and small islet cell clusters for diabetes treatment |
| 09/16/2010 | US20100233215 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND |
| 09/16/2010 | US20100233209 Chikungunya virus infectious clones and uses therefor |
| 09/16/2010 | US20100233187 Gene products differentially expressed in cancerous cells |
| 09/16/2010 | US20100233185 Caries Risk Test for Predicting and Assessing the Risk of Disease |